C&W releases white paper on real estate implications of the sector’s growth;
launches Global Life Science Practice Group
In conjunction with the launch of a Global Life Science Practice Group, Cushman &
Wakefield today released a comprehensive report on the commercial real estate implications of
the growing life sciences sector. The report anticipates continued growth for the sector
and increased demand for life-sciences specific real estate in San Francisco and several other
U.S. markets.
Considered by most to be the birthplace of the biotechnology industry, the San Francisco
market is currently experiencing a very low market vacancy of around 7 percent. The area
is home to the venture capital industry, which helps attract start up firms to the market. The
market is also benefiting from large expansions by companies such as PDL BioPharma, Gilead,
Fibrogen and Genentech.
“South San Francisco is the largest life sciences market in the United States,”
says John Minervini, Executive Director and Managing Principal of Cushman &
Wakefield’s Global Life Science Practice Group. “The recent announcement of
the sale of the Slough portfolio to HCPI has added a third major investor to this dynamic
market.”
The report, Life Sciences Sector Drives Real Estate Growth, was produced by Cushman &
Wakefield’s Research professionals Maria Sicola, Rick Cleveland and Mark Urbanowicz,
based on published and proprietary market data with input and additional analysis from
principals of the firm’s newly formed Global Life Science Practice Group.
According to Ms. Sicola, executive managing director and head of Cushman & Wakefield
Research Services in the U.S., major findings of the report point to strength in the life
sciences sector overall, including an abundance of capital earmarked for expansion and
increased corporate activity, as well as the emergence of life sciences “clusters”
in select U.S. markets that have attracted significant numbers of firms to specific
locations. All of this, said Ms. Sicola, accounts for “a noticeable increase in
demand for properties catering to life sciences – from investors and
companies.”
The life sciences sector has benefited from strong demographics, including the aging
baby-boomer population in the U.S., technological advances in research and development and
increases in prescription drug spending. These trends are positioning life sciences
assets for long-term growth, according to the report, based on sector growth and the fact that
life sciences firms typically sign long-term leases.
The report also cites growing investment demand for life sciences properties. In 2006,
227 life sciences related assets traded for a total of $5.1 billion, up from $601 million in
2002, according to data compiled by Real Capital Analytics. San Francisco remains the
nation’s top life sciences market, with up to 30 million square feet of inventory.
The report also looks at developing life sciences markets including the New York metro area and
its surrounding suburbs, suburban Maryland, Raleigh Durham, N.C., Puerto Rico, Seattle and
metro Los Angeles.
Cushman & Wakefield’s Global Life Science Practice Group brings together brokerage
specialists and consulting partners to meet the unique requirements of companies in the life
sciences industry. Members of the group have developed broad expertise in the life
sciences arena, demonstrating an understanding of the industry and its specific needs, how the
industry interacts with government agencies for funding and incentives, and an ability to help
clients identify and implement real estate solutions that support core financial and operating
strategies.
In addition to Mr. Minervini, who is based in Los Angeles, members of the Global Life
Science Practice Group include Executive Director Christopher Kinum, East Rutherford, N.J.;
Executive Director Mark Winters, Boston; Senior Director Thomas Giannone, East Rutherford;
Partner Nick Giraudeau, Madrid, Spain; as well as Consulting Partners Jim Reeb, Bob Hess,
France Houdard and Matt Jackson.
A complete copy of the 22-page report may be obtained by written request to
rick.cleveland@cushwake.com.